August 11, 2025, Solon, OH: HospiceChoice Rx is pleased to announce that Shelly Mikuls, current Director of Business Development, has been promoted to the position of President of HospiceChoice Rx.
HospiceChoice Rx CEO Nick Opalich said, “Shelly started with HospiceChoice Rx in January of this year, and made an immediate impact on our business. Shelly has played a crucial role in enhancing our training initiatives for hospice care teams, in mentoring our regional sales directors, and securing new business partnerships. This is a well-deserved promotion, and I’m excited with work with Shelly to continue to grow HospiceChoice Rx.”
A social worker by trade with a master’s degree from Washington University’s George Warren Brown School of Social Work, Mikuls began her career in the long-term care sector. Over the years, she advanced into leadership roles, including Executive Director at a start-up Hospice and Manager of Support Services at a Hospice PBM. As a result, Ms. Mikuls has a deep understanding of both the clinical and operational sides of Hospice organizations through helping her Hospice clients navigate their real-world, daily challenges. She is also well versed in CMS accreditation processes and current regulatory guidelines.
Mikuls shared her excitement for her new role, saying, “I am honored and ecstatic to accept this promotion. When I started at HospiceChoice Rx earlier this year, I was looking forward to working for a company that focuses solely on Hospice and understands and invests in new technologies to provide great value to our Hospice clients. I know and have seen how our innovative approach to Hospice PBM services leads to improved efficiencies and clinical outcomes. I look forward to leading our expert team to the next level in expanding awareness and usage of our revolutionary NaviScript platform.”
About HospiceChoice Rx
HospiceChoice Rx delivers modern pharmacy benefits exclusively for Hospice and Palliative Care organizations through its advanced NaviScript platform. NaviScript streamlines clinician ePrescribing, integrates with Hospice EMRs to reduce dual entry, and lessens administrative burden—freeing more time for patient care. With a nationwide network of over 75,000 pharmacies and partnerships with preferred providers, HospiceChoice Rx ensures patients have reliable access to medications wherever they reside. The company also offers expert PharmD clinical consultations to advise on therapeutic alternatives and deprescribing, supporting cost-effective, high-quality patient care. Learn more at www.hospicechoicerx.com